谁患有晚期心力衰竭？：定义与流行病学
Who has advanced heart failure?: definition and epidemiology.
作者信息
Abouezzeddine Omar F, Redfield Margaret M
机构信息
Division of Cardiovascular Diseases and Internal Medicine Mayo Clinic, Rochester, MN, USA.
出版信息
Congest Heart Fail. 2011 Jul-Aug;17(4):160-8. doi: 10.1111/j.1751-7133.2011.00246.x. Epub 2011 Jul 21.
Abstract
Summarizing current guidelines and advanced heart failure (AHF) clinical trials/registries, this review focuses on the current definition of AHF and emphasizes the secular trends in this definition over the last two decades. Further, clinical, imaging, hemodynamic, functional capacity and biomarker parameters that may aid clinicians to better recognize patients with AHF are reviewed. Finally, we review the limited data concerning the epidemiology of AHF which to date has been poorly characterized.
摘要
本综述总结了当前的指南以及晚期心力衰竭（AHF）临床试验/登记研究，重点关注AHF的当前定义，并强调了过去二十年中该定义的长期趋势。此外，还综述了可能有助于临床医生更好地识别AHF患者的临床、影像学、血流动力学、功能能力和生物标志物参数。最后，我们回顾了关于AHF流行病学的有限数据，迄今为止，这些数据的特征尚不明确。
相似文献
1
Who has advanced heart failure?: definition and epidemiology.谁患有晚期心力衰竭？：定义与流行病学
Congest Heart Fail. 2011 Jul-Aug;17(4):160-8. doi: 10.1111/j.1751-7133.2011.00246.x. Epub 2011 Jul 21.
2
Heart failure epidemiology: European perspective.心力衰竭流行病学：欧洲视角
Curr Cardiol Rev. 2013 May;9(2):123-7. doi: 10.2174/1573403x11309020005.
3
Duration of Heart Failure Is an Important Predictor of Outcomes After Mechanical Circulatory Support.心力衰竭的持续时间是机械循环支持后预后的重要预测指标。
Circ Heart Fail. 2015 Sep;8(5):953-9. doi: 10.1161/CIRCHEARTFAILURE.115.002321. Epub 2015 Aug 6.
4
Mechanical approach in the management of advanced acute and chronic heart failure: the state of the art.机械方法在急性和慢性心力衰竭的治疗中的应用：最新进展。
Angiology. 2015 Feb;66(2):104-13. doi: 10.1177/0003319714521494. Epub 2014 Feb 24.
5
Cardiac resynchronization therapy: implant rates, temporal trends and relationships with heart failure epidemiology.心脏再同步治疗：植入率、时间趋势及其与心力衰竭流行病学的关系。
J Cardiovasc Med (Hagerstown). 2014 Feb;15(2):147-54. doi: 10.2459/JCM.0b013e3283638d90.
6
Echocardiography-guided biventricular pacemaker optimization.超声心动图引导的双心室起搏器优化。
JACC Cardiovasc Imaging. 2010 Nov;3(11):1168-80. doi: 10.1016/j.jcmg.2010.06.017.
7
Gauging the response to cardiac resynchronization therapy: The important interplay between predictor variables and definition of a favorable outcome.评估心脏再同步治疗的反应：预测变量与良好结局定义之间的重要相互作用。
Echocardiography. 2017 Mar;34(3):371-375. doi: 10.1111/echo.13453. Epub 2017 Jan 11.
8
Contemporary profile of acute heart failure in Southern Nigeria: data from the Abeokuta Heart Failure Clinical Registry.当代尼日利亚南部急性心力衰竭的特征：来自阿贝奥库塔心力衰竭临床登记处的数据。
JACC Heart Fail. 2014 Jun;2(3):250-9. doi: 10.1016/j.jchf.2013.12.005. Epub 2014 Apr 30.
9
Maximum derivative of left ventricular pressure predicts cardiac mortality after cardiac resynchronization therapy.左心室压力最大导数可预测心脏再同步化治疗后的心脏死亡率。
Clin Cardiol. 2010 Dec;33(12):E18-23. doi: 10.1002/clc.20683. Epub 2010 Dec 8.
10
Cardiac resynchronization therapy and its role in the management of heart failure.心脏再同步治疗及其在心力衰竭管理中的作用。
Br J Hosp Med (Lond). 2017 Jun 2;78(6):312-319. doi: 10.12968/hmed.2017.78.6.312.
引用本文的文献
1
Health-related quality of life and associated factors among individuals with heart failure attending public hospitals in Nekemte town, Western Oromia, Ethiopia: a cross-sectional study.埃塞俄比亚奥罗米亚西部内克梅特镇公立医院心力衰竭患者的健康相关生活质量及其相关因素：一项横断面研究。
BMC Cardiovasc Disord. 2025 Jul 28;25(1):550. doi: 10.1186/s12872-025-05007-w.
2
Transition to Advanced Heart Failure: From Identification to Improving Prognosis.向晚期心力衰竭的转变：从识别到改善预后
J Cardiovasc Dev Dis. 2025 Mar 17;12(3):104. doi: 10.3390/jcdd12030104.
3
Impaired Cardiac Sympathetic Activity Is Associated With Myocardial Remodeling and Established Biomarkers of Heart Failure.心脏交感神经活动受损与心肌重构和心力衰竭的既定生物标志物有关。
J Am Heart Assoc. 2024 Jul 16;13(14):e035264. doi: 10.1161/JAHA.124.035264. Epub 2024 Jul 3.
4
Randomised pilot study comparing a coach to SMARTPhone reminders to aid the management of heart failure (HF) patients: humans or machines.随机试点研究比较了教练和智能手机提醒在帮助心力衰竭 (HF) 患者管理中的作用：人类还是机器。
BMJ Open Qual. 2024 Jul 1;13(3):e002753. doi: 10.1136/bmjoq-2024-002753.
5
Clinical evidence and potential mechanisms of traditional Chinese medicine for refractory heart failure: a literature review and perspectives.中药治疗难治性心力衰竭的临床证据及潜在机制：文献综述与展望
Front Cardiovasc Med. 2024 Apr 23;11:1369642. doi: 10.3389/fcvm.2024.1369642. eCollection 2024.
6
The effects of demographic, psychosocial, and socioeconomic characteristics on access to heart transplantation and left ventricular assist device.人口统计学、心理社会和社会经济特征对心脏移植及左心室辅助装置获取的影响。
Am Heart J Plus. 2022 Jul 5;17:100172. doi: 10.1016/j.ahjo.2022.100172. eCollection 2022 May.
7
Disparities by Sex, Race, and Ethnicity in Use of Left Ventricular Assist Devices and Heart Transplants Among Patients With Heart Failure With Reduced Ejection Fraction.心力衰竭伴射血分数降低患者中左心室辅助装置和心脏移植在性别、种族和民族方面的差异。
J Am Heart Assoc. 2024 Jan 16;13(2):e031021. doi: 10.1161/JAHA.123.031021. Epub 2024 Jan 3.
8
Non-Medical Characteristics Affect Referral for Advanced Heart Failure Services: a Retrospective Review.非医学特征对晚期心力衰竭服务转诊的影响：一项回顾性研究。
J Racial Ethn Health Disparities. 2025 Feb;12(1):374-383. doi: 10.1007/s40615-023-01879-w. Epub 2023 Dec 1.
9
Advanced Heart Failure Characteristics and Outcomes in Commercially Insured U.S. Adults.商业保险覆盖的美国成年人中心衰特征和结局的研究
JACC Heart Fail. 2023 Nov;11(11):1595-1606. doi: 10.1016/j.jchf.2023.06.029. Epub 2023 Aug 16.
10
Group Dynamics and Allocation of Advanced Heart Failure Therapies-Heart Transplants and Ventricular Assist Devices-By Gender, Racial, and Ethnic Group.群体动力学与心力衰竭先进治疗方法（心脏移植和心室辅助设备）的分配-按性别、种族和族裔群体。
J Am Heart Assoc. 2023 Mar 7;12(5):e027701. doi: 10.1161/JAHA.122.027701. Epub 2023 Feb 27.
本文引用的文献
1
Left ventricular assist devices are underutilized.左心室辅助装置未得到充分利用。
Circulation. 2011 Apr 12;123(14):1552-8; discussion 1558. doi: 10.1161/CIRCULATIONAHA.110.958991.
2
Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification.根据术前 INTERMACS 分类对连续血流左心室辅助装置患者的临床结局进行分层。
J Heart Lung Transplant. 2011 Apr;30(4):402-7. doi: 10.1016/j.healun.2010.10.016. Epub 2010 Dec 18.
3
Heart disease and stroke statistics--2011 update: a report from the American Heart Association.心脏病和中风统计数据--2011 年更新：来自美国心脏协会的报告。
Circulation. 2011 Feb 1;123(4):e18-e209. doi: 10.1161/CIR.0b013e3182009701. Epub 2010 Dec 15.
4
Lifetime costs of medical care after heart failure diagnosis.心力衰竭诊断后的终身医疗费用。
Circ Cardiovasc Qual Outcomes. 2011 Jan 1;4(1):68-75. doi: 10.1161/CIRCOUTCOMES.110.957225. Epub 2010 Dec 7.
5
Epidemiology and risk profile of heart failure.心力衰竭的流行病学和风险特征。
Nat Rev Cardiol. 2011 Jan;8(1):30-41. doi: 10.1038/nrcardio.2010.165. Epub 2010 Nov 9.
6
Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee.西雅图心力衰竭模型在门诊心力衰竭患者中应用于高级心力衰竭治疗委员会。
Circ Heart Fail. 2010 Nov;3(6):706-14. doi: 10.1161/CIRCHEARTFAILURE.110.944280. Epub 2010 Aug 26.
7
HFSA 2010 Comprehensive Heart Failure Practice Guideline.HFSA 2010 全面心力衰竭治疗指南。
J Card Fail. 2010 Jun;16(6):e1-194. doi: 10.1016/j.cardfail.2010.04.004.
8
Chronic ambulatory intracardiac pressures and future heart failure events.慢性动态心内压力与未来心力衰竭事件。
Circ Heart Fail. 2010 Sep;3(5):580-7. doi: 10.1161/CIRCHEARTFAILURE.109.923300. Epub 2010 Jun 18.
9
Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score.心力衰竭住院后患者的分诊：ESCAPE（充血性心力衰竭和肺动脉导管插入术有效性评估研究）风险模型和出院评分。
J Am Coll Cardiol. 2010 Mar 2;55(9):872-8. doi: 10.1016/j.jacc.2009.08.083.
10
Patient selection for left ventricular assist devices.左心室辅助装置的患者选择。
Eur J Heart Fail. 2010 May;12(5):434-43. doi: 10.1093/eurjhf/hfq006. Epub 2010 Feb 19.
Zotero 插件